drugset / Trial / NCT06565871
A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effect and safety of HRS9531 Injection in Obese Subjects with Obstructive Sleep Apnea
Timeline
- Start
- 2024-08
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS9531 | Unknown | — | Subcutaneous |
Indications
No indication recorded.